Shaheen presses Senate for $35 insulin cap before midterm recess
AI Summary- Jeanne Shaheen urged Senate leaders to vote on bipartisan insulin cost-cap legislation.
- The bill would limit commercial-insurance insulin costs to $35 and has 28 co-sponsors.
- The Senate HELP Committee approved the measure 17-5 in July, but passage remains uncertain.